Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD

J Med Econ. 2011;14(6):805-15. Epub 2011 Oct 12.

View abstract

Authors

Sun S, Marynchenko M, Banerjee R, Cheng D, Mocarski M, Yin D, Yu AP, Wu EQ